Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2014. Start Trial.
Date Value
November 12, 2026 3.132
November 11, 2026 3.321
November 10, 2026 3.296
November 09, 2026 3.416
November 06, 2026 3.289
November 05, 2026 3.206
November 04, 2026 3.560
November 03, 2026 3.401
November 02, 2026 3.356
October 30, 2026 3.476
October 29, 2026 3.645
October 28, 2026 3.635
October 27, 2026 3.351
October 26, 2026 3.226
October 23, 2026 3.241
October 22, 2026 3.296
October 21, 2026 3.231
October 20, 2026 3.316
October 19, 2026 3.137
October 16, 2026 3.426
October 15, 2026 3.680
October 14, 2026 3.590
October 13, 2026 3.610
October 12, 2026 3.770
October 09, 2026 3.760
Date Value
October 08, 2026 3.745
October 07, 2026 3.605
October 06, 2026 3.660
October 05, 2026 3.615
October 02, 2026 3.471
October 01, 2026 3.635
September 30, 2026 3.825
September 29, 2026 3.323
September 28, 2026 3.232
September 25, 2026 4.075
September 24, 2026 4.146
September 23, 2026 4.222
September 22, 2026 4.434
September 21, 2026 4.218
September 18, 2026 4.218
September 17, 2026 4.282
September 16, 2026 4.168
September 15, 2026 4.303
September 14, 2026 4.527
September 11, 2026 4.429
September 10, 2026 4.484
September 09, 2026 4.843
September 08, 2026 4.801
September 04, 2026 4.493
September 03, 2026 4.493

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
EyePoint, Inc. 0.1583
ANI Pharmaceuticals, Inc. 2.569
Eli Lilly & Co. 33.76
Corcept Therapeutics, Inc. 9.570
Veru, Inc. 1.274

Price to Book Value Related Metrics

PS Ratio 27.63
PEG Ratio -3.156
Price 6.205
Earnings Yield -23.46%
Market Cap 1.364B
PEGY Ratio -3.156